PrescribeToPrevent

Prescribe Naloxone, Save a Life

  • Clinician Resource
    • General
    • Emergency Medicine
    • Substance Use Disorder Treatment
  • OTC Naloxone
  • Patient Education
    • Videos
    • Online Training
    • Materials
  • Policy Resources
    • Research
    • Legal
    • Position Statements
  • FAQ
  • Contact Us

09.09.18

PubMed Update August 2018

26 this month. I’m going to call out paper #3 because I think it’s super important.   1) High buprenorphine-related mortality is persistent in Finland. Kriikku P, Häkkinen M, Ojanperä I. Forensic Sci Int. 2018 Aug 17;291:76-82. doi: 10.1016/j.forsciint.2018.08.010. [Epub ahead of print] Comments: This is an interesting topic. Finland seems to have a lot ofRead More

08.18.18

PubMed Update March-June 2018

Life is busy and so are all these writers – 109 papers. This is four months of article updates so a bit overwhelming. Sorry about that. I tried to help by creating some categories, but there are still 35 uncategorized.   26 naloxone papers:   1) Naloxone prescriptions from the emergency department: An initiative in evolution.Read More

01.02.18

PubMed Update November 2017

In honor of the impending New Year … we have 38 papers for you in just one month! There’s some sophisticated work here – innovative epidemiology, interventions, and reviews of overdose. We’ve come a long way from the 1990s, but clearly not quickly enough for the dynamic urgency of this issue.   1) Safety andRead More

06.07.17

PubMed Update February-May 2017

Sorry this took so long. This was partly due to my schedule and partly because we’ve been in a process of transitioning to PrescribeToPrevent. You can thank those unnamed persons who reached out to me asking when the next installment was coming for avoiding a much greater delay!   108 articles in four months. TheRead More

04.09.16

PubMed Update April 2016

23 for this month! Lots of interesting stuff, from large-scale epidemiology to randomized controlled trials. 1) Pharmacokinetic Properties and Human Use Characteristics of an FDA Approved IntranasalNaloxone Product for the Treatment of Opioid Overdose. Krieter P, Chiang N, Gyaw S, Skolnick P, Crystal R, Keegan F, Aker J, Beck M, Harris J. J Clin Pharmacol. 2016 MayRead More

07.13.15

PubMed Update June – July 2015

Great stuff this time! 34 in two months. Opioid OverdosePrevention Programs Providing Naloxoneto Laypersons – United States, 2014. Wheeler E, Jones TS, Gilbert MK, Davidson PJ. MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):631-5. Comment: The long-awaited sequel to 2010’s blockbuster naloxone MMWR report! 152,283 laypersons trained and 26,463 overdose reversals reported to naloxone programs through 2014.Read More

03.08.15

PubMed Update November 2014 – February 2015

Catching up on 51 papers in 4 months. Did you miss me? 1) New Drugs of Abuse. Rech MA, Donahey E, Cappiello Dziedzic JM, Oh L, Greenhalgh E. Pharmacotherapy. 2014 Dec 4. doi: 10.1002/phar.1522. [Epub ahead of print] Comment: Review of management of drug toxicities among novel, synthetic compounds. 2) Police officer attitudes towards intranasal naloxone training.Read More

03.03.14

PubMed Update February 2014

8 papers today, essentially about naloxone and heroin. 1) Risk of anaphylaxis in opioid dependent persons: effects of heroin versus substitution substance. Maurer U, Kager C, Fellinger C, Loader D, Pollesböck A, Spitzer B, Jarisch R. Subst Abuse Treat Prev Policy. 2014 Feb 27;9(1):12. [Epub ahead of print] Comment: Seeking alternative explanations for “overdose”, theRead More

prescribetoprevent@gmail.com

site by: web360

  • Clinician Resource
    • General
    • Emergency Medicine
    • Substance Use Disorder Treatment
  • OTC Naloxone
  • Patient Education
    • Videos
    • Online Training
    • Materials
  • Policy Resources
    • Research
    • Legal
    • Position Statements
  • FAQ

Copyright 2022 PrescribeToPrevent.org